Abstract:Thoracic aortic disease affects people of all ages and the majority of those aged <60 years have an underlying genetic cause. There is presently no effective medical therapy for thoracic aneurysm and surgery remains the principal intervention. Unlike abdominal aortic aneurysm, for which the inflammatory/atherosclerotic pathogenesis is well established, the mechanism of thoracic aneurysm is less understood. This paper examines the key cell signaling systems responsible for the growth and development of the aorta, homeostasis of endothelial and vascular smooth muscle cells and interactions between pathways. The evidence supporting a role for individual signaling pathways in pathogenesis of thoracic aortic aneurysm is examined and potential novel therapeutic approaches are reviewed. Several key signaling pathways, notably TGF-β, WNT, NOTCH, PI3K/AKT and ANGII contribute to growth, proliferation, cell phenotype and survival for both vascular smooth muscle and endothelial cells. There is crosstalk between pathways, and between vascular smooth muscle and endothelial cells, with both synergistic and antagonistic interactions. A common feature of the activation of each is response to injury or abnormal cell stress. Considerable experimental evidence supports a contribution of each of these pathways to aneurysm formation. Although human information is less, there is sufficient data to implicate each pathway in the pathogenesis of human thoracic aneurysm. As some pathways i.e., WNT and NOTCH, play key roles in tissue growth and organogenesis in early life, it is possible that dysregulation of these pathways results in an abnormal aortic architecture even in infancy, thereby setting the stage for aneurysm development in later life. Given the fine tuning of these signaling systems, functional polymorphisms in key signaling elements may set up a future risk of thoracic aneurysm. Multiple novel therapeutic agents have been developed, targeting cell signaling pathways, predominantly in cancer medicine. Future investigations addressing cell specific targeting, reduced toxicity and also less intense treatment effects may hold promise for effective new medical treatments of thoracic aortic aneurysm.

Progress on the Role of Vascular Endothelial Cells in the Formation of Aortic Aneurysms

The mechanism and therapy of aortic aneurysms

Endothelium as a Potential Target for Treatment of Abdominal Aortic Aneurysm

A review of current status of cell-based therapies for aortic aneurysms

[Autophagy Regulates the Function of Vascular Smooth Muscle Cells in the Formation and Rupture of Intracranial Aneurysms].

Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm

Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm

Macrophage-derived extracellular vesicles and aortic aneurysm

Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression

Cellular Mechanisms of Aortic Aneurysm Formation

Understanding the Potential Function of Perivascular Adipose Tissue in Abdominal Aortic Aneurysms: Current Research Status and Future Expectation

Using Molecular Targets to Predict and Treat Aortic Aneurysms.

Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions

Insights on Aortic Aneurysm and Dissection: Role of the Extracellular Environment in Vascular Homeostasis.

Matricellular Proteins: Potential Biomarkers and Mechanistic Factors in Aortic Aneurysms.

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Aortic aneurysm: pathophysiology and therapeutic options

Molecular targets in aortic aneurysm for establishing novel management paradigms

Potential role of endothelial progenitor cells in the pathogenesis and treatment of cerebral aneurysm

Advances and challenges in regenerative therapies for abdominal aortic aneurysm

Targeting autophagy in aortic aneurysm and dissection